3rd Annual Targeted Protein Degradation Summit - Digital Event

Returning in a digital capacity, the 3rd Targeted Protein Degradation (TPD) Summit is your industry-dedicated platform that is bringing together the pioneering leaders of the biopharmaceutical industry and academia. As the most comprehensive and definitive event for the field of protein degradation, the 3rd TPD Summit is proud to showcase the very latest case studies and unique perspectives from 60+ pioneering experts who are capitalizing on this exciting therapeutic class and breaking new ground to make protein degradation the modality of choice. 

Via the latest data-driven case studies from industry and academic experts, successfully degrade intracellular and extracellular targets, leverage the power of the ubiquitin-proteasome system and autophagy-mediated degradation and optimize drug-like properties of next-generation protein degraders for applications in oncology and beyond. 

As TPD-based therapeutics continues to generate a new frontier in the field of medicine, join C-Level Executives, VPS, and Directors from leading biopharmaceutical organizations at the 3rd TPD Summit to gain a unique insight into the latest developments of the field and walk away with valuable connections and future directions to drive forward your TPD strategies.

Others Details

URL: Brochure: https://go.evvnt.com/664140-3?pid=6581 Speakers: Jay Bradner, President, Novartis Institutes for Biomedical Research, Craig Crews, John C. Malone Professor of MCDB, Chemistry and Pharmacology, Yale University, Alessio Ciulli, Professor of Chemical and Structural Biology, University of Dundee, Matthew Disney, Professor of Chemistry and Neuroscience, Scripps Research, Daniel Nomura, Professor of Chemistry, University of California, Berkeley and more. Time: 08:00 - 17:30